BRINGING QUALITY CANCER TREATMENT EVERYWHERE
At Scandinavian Care, we're transforming cancer treatment with advanced, patient-centered care. Through cutting-edge radiotherapy technology and Swedish expertise, we build modern cancer centers that offer accessible, personalized care. For patients, this means better outcomes and support; for investors, it's a chance to drive innovation and expand global access to world-class healthcare.
Our Projects
Scandinavian Care has successfully delivered investment and consultancy projects worldwide, establishing advanced cancer centers in Africa, South America, Europe, and the Middle East.
With over 40,000 patients treated since our journey began, we are committed to delivering innovative healthcare solutions tailored to the needs of diverse regions. From designing state-of-the-art facilities with cutting-edge radiotherapy technologies to training local medical professionals, we ensure each center upholds the highest standards of care.
By fostering long-term partnerships and integrating Swedish expertise, we empower communities to access advanced cancer treatments, improve healthcare outcomes, and build sustainable healthcare systems. Scandinavian Care is proud to transform cancer care and make a lasting impact globally.
Sustainability
Scandinavian Care’s corporate responsibility focuses on ethical practices, social impact, and environmental sustainability. We uphold integrity and transparency, improve healthcare access through cancer centers in underserved regions, and invest in local development. By adopting eco-friendly technologies and reducing waste, we ensure our operations align with sustainability, combining ethics and innovation to transform global cancer care responsibly. Read more.
Cases of cancer per 100.000 population
Cancer is a leading global health challenge, with approximately 19.3 million new cases and 10 million deaths annually. Lung, breast, colorectal, and prostate cancers are among the most common, with incidence rates varying widely across regions due to factors like aging populations, lifestyle changes, and healthcare access. While high-income countries report higher rates due to advanced diagnostics, low- and middle-income countries are experiencing a surge driven by lifestyle shifts and limited preventive measures. Key contributors include smoking, obesity, and inactivity, though initiatives like HPV and hepatitis B vaccinations and early screening have shown promise in reducing specific cancer types. By 2040, global cases are projected to reach 28 million, emphasizing the need for prevention, equitable treatment access, and healthcare improvements worldwide.
